Published in Nat Rev Genet on December 28, 2016
Genetic Approaches to Understanding Psychiatric Disease. Neurotherapeutics (2017) 0.80
Dosage-sensitive genes in evolution and disease. BMC Biol (2017) 0.75
Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits. Mol Genet Genomic Med (2017) 0.75
Predispositions to Leukemia in Down Syndrome and Other Hereditary Disorders. Curr Treat Options Oncol (2017) 0.75
A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down's syndrome (DS; trisomy 21). J Nat Sci (2017) 0.75
Diagnosis and classification of hematologic malignancies on the basis of genetics. Blood (2017) 0.75
An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73
Mapping and analysis of chromatin state dynamics in nine human cell types. Nature (2011) 24.37
Repbase Update, a database of eukaryotic repetitive elements. Cytogenet Genome Res (2005) 23.41
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet (1999) 22.84
GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res (2012) 19.19
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics (2003) 17.92
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Genetic mapping in human disease. Science (2008) 15.12
Mechanisms and functional implications of adult neurogenesis. Cell (2008) 14.50
Analysis of protein-coding genetic variation in 60,706 humans. Nature (2016) 11.83
Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature (2008) 10.95
The DNA sequence of human chromosome 21. Nature (2000) 10.66
Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science (2015) 9.92
Cerebral organoids model human brain development and microcephaly. Nature (2013) 9.07
Presence of fetal DNA in maternal plasma and serum. Lancet (1997) 9.01
Transcriptome and genome sequencing uncovers functional variation in humans. Nature (2013) 8.89
The human XIST gene: analysis of a 17 kb inactive X-specific RNA that contains conserved repeats and is highly localized within the nucleus. Cell (1992) 8.05
An expansive human regulatory lexicon encoded in transcription factor footprints. Nature (2012) 7.27
Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci U S A (2008) 5.94
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science (1982) 5.63
Down's syndrome. Lancet (2003) 5.10
Characterising and predicting haploinsufficiency in the human genome. PLoS Genet (2010) 4.85
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia. Nat Genet (2009) 4.35
A chromosome 21 critical region does not cause specific Down syndrome phenotypes. Science (2004) 4.16
Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet (2000) 3.84
Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol (1985) 3.83
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome. Nat Neurosci (2007) 3.74
Chromosome 21 and down syndrome: from genomics to pathophysiology. Nat Rev Genet (2004) 3.58
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration. Neuron (2006) 3.51
Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. N Engl J Med (1989) 3.24
Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol (2000) 2.78
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome. J Neurosci (2004) 2.73
Presence of soluble amyloid beta-peptide precedes amyloid plaque formation in Down's syndrome. Nat Med (1996) 2.71
Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife (2013) 2.70
Coordinated effects of sequence variation on DNA binding, chromatin structure, and transcription. Science (2013) 2.66
Human microRNA-155 on chromosome 21 differentially interacts with its polymorphic target in the AGTR1 3' untranslated region: a mechanism for functional single-nucleotide polymorphisms related to phenotypes. Am J Hum Genet (2007) 2.62
Congenital cardiovascular malformations associated with chromosome abnormalities: an epidemiologic study. J Pediatr (1989) 2.55
Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation. Neurobiol Dis (1996) 2.50
Memory enhancement induced by hypothalamic/fornix deep brain stimulation. Ann Neurol (2008) 2.46
The genetic architecture of Down syndrome phenotypes revealed by high-resolution analysis of human segmental trisomies. Proc Natl Acad Sci U S A (2009) 2.36
Ts1Cje, a partial trisomy 16 mouse model for Down syndrome, exhibits learning and behavioral abnormalities. Proc Natl Acad Sci U S A (1998) 2.32
Domains of genome-wide gene expression dysregulation in Down's syndrome. Nature (2014) 2.30
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation. Blood (2003) 2.21
Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice. Nature (2015) 2.18
Gene duplication: a drive for phenotypic diversity and cause of human disease. Annu Rev Genomics Hum Genet (2007) 2.16
Human chromosome 21 dosage: effect on the expression of the interferon induced antiviral state. Science (1974) 1.95
A human stem cell model of early Alzheimer's disease pathology in Down syndrome. Sci Transl Med (2012) 1.95
Synaptic structural abnormalities in the Ts65Dn mouse model of Down Syndrome. J Comp Neurol (2004) 1.92
Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur J Hum Genet (2008) 1.90
Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am J Hum Genet (2007) 1.86
Population Variation and Genetic Control of Modular Chromatin Architecture in Humans. Cell (2015) 1.85
Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood (2009) 1.84
Segmental trisomy of murine chromosome 16: a new model system for studying Down syndrome. Prog Clin Biol Res (1990) 1.84
Incidence and treatment of potentially lethal diseases in transient leukemia of Down syndrome: Pediatric Oncology Group Study. J Pediatr Hematol Oncol (2002) 1.78
Translating dosage compensation to trisomy 21. Nature (2013) 1.75
Too much of a good thing: mechanisms of gene action in Down syndrome. Trends Genet (2001) 1.72
MicroRNA regulation of Cbx7 mediates a switch of Polycomb orthologs during ESC differentiation. Cell Stem Cell (2012) 1.72
Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model. Sci Transl Med (2013) 1.70
Triplication of a 21q22 region contributes to B cell transformation through HMGN1 overexpression and loss of histone H3 Lys27 trimethylation. Nat Genet (2014) 1.67
Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells. Proc Natl Acad Sci U S A (2012) 1.62
GATA1-mutant clones are frequent and often unsuspected in babies with Down syndrome: identification of a population at risk of leukemia. Blood (2013) 1.60
Duplication of the entire 22.9 Mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet (2007) 1.57
Promoter mutations that increase amyloid precursor-protein expression are associated with Alzheimer disease. Am J Hum Genet (2006) 1.55
Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.54
Bidirectional changes to hippocampal theta-gamma comodulation predict memory for recent spatial episodes. Proc Natl Acad Sci U S A (2010) 1.51
Molecular mapping of Alzheimer-type dementia in Down's syndrome. Ann Neurol (1998) 1.50
Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med (2001) 1.49
Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci (2007) 1.48
Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci U S A (2006) 1.47
Intragenic deletion in DYRK1A leads to mental retardation and primary microcephaly. Clin Genet (2011) 1.46
A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions. Hum Mol Genet (2010) 1.42
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis. Br J Haematol (2009) 1.38
Trisomy correction in Down syndrome induced pluripotent stem cells. Cell Stem Cell (2012) 1.35
Origins of leukaemia in children with Down syndrome. Nat Rev Cancer (2005) 1.35
Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome. Exp Neurol (2000) 1.35
Leukemia in Down syndrome: a review. Pediatr Hematol Oncol (1992) 1.35
Human pluripotent stem cells: applications and challenges in neurological diseases. Front Physiol (2012) 1.31
The landscape of somatic mutations in Down syndrome-related myeloid disorders. Nat Genet (2013) 1.31
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol Med (2013) 1.30
Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia (2003) 1.28
Cytoskeletal pathologies of Alzheimer disease. Cell Motil Cytoskeleton (2009) 1.28
The challenge of Down syndrome. Trends Mol Med (2006) 1.28
Alzheimer-like cholinergic deficiency in Down syndrome. Lancet (1980) 1.26
Mice containing a human chromosome 21 model behavioral impairment and cardiac anomalies of Down's syndrome. Hum Mol Genet (2001) 1.24
A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome. Hum Mol Genet (2009) 1.20
Role of astroglia in Down's syndrome revealed by patient-derived human-induced pluripotent stem cells. Nat Commun (2014) 1.18
Massive-scale RNA-Seq analysis of non ribosomal transcriptome in human trisomy 21. PLoS One (2011) 1.15
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res (2013) 1.15
Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci (2010) 1.14
Down's syndrome-like cardiac developmental defects in embryos of the transchromosomic Tc1 mouse. Cardiovasc Res (2010) 1.13
Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome. Exp Neurol (2006) 1.12
miR-99a/100~125b tricistrons regulate hematopoietic stem and progenitor cell homeostasis by shifting the balance between TGFβ and Wnt signaling. Genes Dev (2014) 1.11
Green tea polyphenols rescue of brain defects induced by overexpression of DYRK1A. PLoS One (2009) 1.10
Down syndrome: the brain in trisomic mode. Nat Rev Neurosci (2012) 1.10
Ts65Dn mice, a model for Down syndrome, have deficits in context discrimination learning suggesting impaired hippocampal function. Behav Brain Res (2001) 1.09
Perinatal choline supplementation improves cognitive functioning and emotion regulation in the Ts65Dn mouse model of Down syndrome. Behav Neurosci (2010) 1.09
Reducing GABAA α5 receptor-mediated inhibition rescues functional and neuromorphological deficits in a mouse model of down syndrome. J Neurosci (2013) 1.07
Deficits in human trisomy 21 iPSCs and neurons. Proc Natl Acad Sci U S A (2013) 1.07
10 years of Genomics, chromosome 21, and Down syndrome. Genomics (1998) 1.07